SIF

Poster Session Abstracts
P-IV - Pharmacovigilance; Paediatric Pharmacology


AN UNCOMMON STEVEN-JOHNSON SYNDROME INDUCED BY AΒETA-AGONIST AGENT IN A 6-YEARS-OLD CHILD
Lenti M., Lombardi N., Faginali B., Maggini V., Pugi A., Moschini M., Bonaiuti R., Gallo E., Mugelli A., Vannacci A.
SEVERE INTUSSUSCEPTION AFTER ADMINISTRATION OF ANTI-ROTAVIRUS VACCINE: CASE SERIES
Pugi A., Lenti M., Maggini V., Lombardi N., Gallo E., Bonaiuti R., Lucenteforte E., Moschini M., Calvani A., Mannelli F., Innocenti L., Parrilli M., Rossi M., Mugelli A., Vannacci A.
A CASE OF HEPATOTOXICITY BY PELARGONIUM SIDOIDES
Lenti M., Baldini A., Cecchi E., Bonaiuti R., Gallo E., Pugi A., Maggini V., Firenzuoli F., Lombardi N., Lucenteforte E., Moschini M., Mugelli A., Vannacci A.
ALLERGIC ACUTE CORONARY SYNDROME (KOUNIS SYNDROME): REPORT OF 3 CASES SECONDARY TO ORAL AMOXICILLIN USE
Lombardi N., Pugi A., Maggini V., Moschini M., Lenti M., Gallo E., Lucenteforte E., Mugelli A., Cecchi E., Vannacci A.
PHYTO.VIG.GEST.:A MULTICENTER OBSERVATIONAL STUDY ON CONSUMPTION AND EFFECTS OF DRUGS AND FOOD SUPPLEMENTS IN PREGNANCY
Dante G., Miroddi M., Facchinetti F., Mannucci C., Mancari F., Calapai F., Lenti M., Vannacci A., Perone M., Cafeo V., Calapai G.
POSSIBLE ASSOCIATION BETWEEN NORETHISTERONE AND PARAESTHESIA: DATA FROM THE VIGIBASE
Buccellato E., Biagi C., Vaccheri A., Melis M., Montanaro N., Motola D.
ADVERSE DRUG REACTIONS INDUCEDRELATED TOANTIHYPERTENSIVE DRUG TREATMENT: A RETROSPECTIVE STUDY IN CALABRIA
Rende P., Paletta L., Gratteri S., Giofrè C., Russo E., De Sarro G., Gallelli L.
FACTORS INFLUENCING THE DISPROPORTIONAL ASSOCIATION BETWEEN TRIPTANS AND CEREBROVASCULAR EVENTS WITHIN THE FDA_AERS DATABASE: CAUSAL ASSOCIATION OR REPORTING BIAS?
Roberto G., Piccinni C., Poluzzi E.
THE PROJECT OF ACTIVE PHARMACOVIGILANCE “MEREAFAPS” AS A TOOL TO ANALYZE AND CONSEQUENTLY TO IMPROVE THE USE OF DRUGS IN THE PATIENT PATHWAY BETWEEN HOSPITAL AND TERRITORY: FIRST ASLTO4 DATA

Bianco S., Aimino M., Rocatti L., Morello M.
DISEASE-RELATED ADVERSE EVENTS FOLLOWING NON-LIVE VACCINES: ANALYSIS OF THE WHO GLOBAL ICSRS DATABASE, VIGIBASE
Roberto G., Zanoni G.
PROVIDING RELIABLE INFORMATION ON PHARMACOVIGILANCE VIA THE WEB: A LONG-TERM EXPERIENCE OF AN ITALIAN WEB SITE
Polimeni G., Russo A., Fava G., Pizzimenti V., Lo Giudice I., Ingrasciotta Y., Minutoli L., Trifirò G., Calapai G., Altavilla D., Sautebin L., Caputi A.
DRUG USE DURING PREGNANCY: REPORT FROM THE REGIONAL PHARMACOVIGILANCE CENTRE OF CATANIA
Longo L., Gozzo L., Drago F., Navarria A., Sinagra T., Urso V.
THE DEVELOPMENT OF A PHARMACOVIGILANCE NETWORK IN SARDINIA.
Deidda A., Carta P., Chillotti C., Tidore M., Piras F., Del Zompo M., Garau D., Stochino M.
ADVERSE EVENTS FOLLOWING IMMUNIZATION (AEFI) IN EMERGENCY DEPARTMENT: RESULTS OF MEREAFAPS STUDY
Saporiti A., Blandizzi C., Ruggiero E., Rossi M., Capogrosso-Sansone A., Moschini M., Rimoli F., Cecchi E., Vannacci A., Montagnani S., Mantarro S., Lombardi N., Santini M., Spisni L., Mannelli F., Verzuri M., Tuccori M.
PHARMACOVIGILANCE AND DRUG SAFETY IN CALABRIA (ITALY): 2012 ADVERSE EVENTS ANALYSIS
De Sarro G., Giofrè C., Scicchitano F., Palleria C., Gallelli L., Russo E., Univigil Research Group .
EXOSTOSIS INDUCED BY SOMATROPIN THERAPY IN PAEDIATRIC PATIENTS: AN UNKNOWN, BUT PREDICTABLE, ADVERSE REACTION.
Gentili M., Carnovale C., Beretta S., Zuccotti G., Guazzarotti L., Pellegrino P., Antoniazzi S., Salvati D., Perrone V., Pozzi M., Clementi E., Radice S.
THE IMPORTANCE OF SPONTANEOUS REPORTING IN GERIATRICS: THE VIGER PROJECT
Salvati D., Carnovale C., Pellegrino P., Gentili M., Perrone V., Antoniazzi S., Pozzi M., Clementi E., Radice S.
USE OF ANTIHISTAMINES AND RISK OF VENTRICULAR ARRHYTHMIA: A NESTED CASE-CONTROL MULTI-DATABASE STUDY IN 5 EUROPEAN COUNTRIES
Poluzzi E., Koci A., Oteri A., Pecchioli S., Bezemer I., Schink T., Frøslev T., De Ridder M., Sturkenboom M., Trifirò G.
DRUG-DRUG INTERACTIONS IN ELDERLY PATIENTS: A 1-YEAR PROSPECTIVE SURVEY IN AN EMERGENCY DEPARTMENT
Capogrosso-Sansone A., Blandizzi C., Montagnani S., Ruggiero E., Mantarro S., Saporiti A., Felici S., Marino A., Pasqualetti G., Monzani F., Santini M., Tuccori M.
PARAESTHESIA AFTER LOCAL ANESTHETICS: AN ANALYSIS OF REPORTS TO THE FDA ADVERSE EVENT REPORTING SYSTEM
Piccinni C., Gissi D., Koci A., Servidio D., Cervellati F., Poluzzi E.
ADVERSE REACTIONS TO BIOLOGICAL MEDICINAL PRODUCTS: ANALYSIS FROM THE ITALIAN SPONTANEOUS REPORTING SYSTEM
Cutroneo P., Russo A., Sirianni C., Pizzimenti V., D'Addetta G., Ruggeri S., Matarangolo E., Sottosanti L., Caputi A., Trifirò G.
MONITORING OF ADVERSE EVENTS IN PAEDIATRICS (MEAP) PROJECT: PRELIMINARY RESULTS
Sullo M., Rafaniello C., Sportiello L., Parretta E., Ferrajolo C., Bernardi F., Carnovale C., Radice S., Clementi E., Rossi F., Capuano A.
ARE MEDICINES AN ADDITIONAL SOURCE OF PHOSPHATE TO BE CONSIDERED IN PATIENTS WITH CHRONIC KIDNEY DISEASE?
Sultana J., Savica V., Ingrasciotta Y., Giorgianni F., Caputi A., Arcoraci V., Tari M., Santoro D., Trifirò G.
ACUTE DISSEMINATED ENCEPHALOMYELITIS FOLLOWING VACCINATION. EPIDEMIOLOGICAL EVALUATION BASED ON PASSIVE ADVERSE EVENTS REPORTING SYSTEMS
Pellegrino P., Carnovale C., Perrone V., Antoniazzi S., Pozzi M., Clementi E., Radice S.
ADVERSE REACTIONS WITH ANTIDIABETIC DRUGS: RESULTS FROM A PROSPECTIVE COHORT STUDY IN SICILY
Pizzimenti V., Ientile V., Fava G., Lo Giudice I., Bonfiglio C., Alecci U., Russo A., Giandalia A., Cutroneo P., Cucinotta D., Caputi A., Trifirò G.
PROTON PUMP INHIBITORS IN THE PREVENTION OF NSAID-RELATED GASTROINTESTINAL INJURY AT HOSPITAL DISCHARGE: ARE THEY USED APPROPRIATELY?
Montagnani S., Tuccori M., Testi A., Cristofano M., Filippi M., Benvenuti D., Capogrosso-Sansone A., Ruggiero E., Mantarro S., Saporiti A., Fornai M., Antonioli L., Corona T., Blandizzi C.
SURVEILLANCE OF ADVERSE REACTIONS TO VACCINES LEADING CHILDREN TO THE EMERGENCY DEPARTMENT
Altavilla D., Mecchio A., Antoci R., Menniti Ippolito F., Arrigo T., Cutroneo P., Caputi A.